Genel, Baby Boy .
HRN: 22-76-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/01/2023
04/07/2023
IV
55mg
Q24hr
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes